Summary Summary Short summary of a recent publication, written by scientific experts. Published: 15 Dec 2022

Impact of demographic and clinical characteristics on risk of severe COVID-19 in patients with neuromuscular disease

Takeaway

  • Among patients with neuromuscular diseases (NMDs), demographic and clinical characteristics confer differential risk of severe COVID-19 outcomes.

Why this matters

  • There is a paucity of data regarding the risk and outcomes of COVID-19 in patients with NMDs.

  • Understanding the risk factors associated with severe COVID-19 in these patients can aid in identifying and optimizing management of vulnerable patient populations.